title: In vitro susceptibility of clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) to manufactured generic drugs compared with the brand vancomycin.
authors.forename: Shigeru
authors.initials: S
authors.lastname: Fujimura
authors.forename: Akira
authors.initials: A
authors.lastname: Watanabe
authors.forename: Katsuhiro
authors.initials: K
authors.lastname: Fuse
authors.forename: Toshiaki
authors.initials: T
authors.lastname: Kikuchi
authors.forename: Kazunori
authors.initials: K
authors.lastname: Gomi
authors.forename: Yutaka
authors.initials: Y
authors.lastname: Tokue
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D016568:Drugs, Generic / Q000494:pharmacology*; D016106:Methicillin Resistance; D008826:Microbial Sensitivity Tests; D013211:Staphylococcus aureus / Q000187:drug effects*; D013810:Therapeutic Equivalency; D014640:Vancomycin / Q000494:pharmacology*
chemical_list: D000900:Anti-Bacterial Agents; D016568:Drugs, Generic; D014640:Vancomycin